SNTI
Senti Biosciences Inc
NASDAQ: SNTI · HEALTHCARE · BIOTECHNOLOGY
$0.92
-5.99% today
Updated 2026-04-30
Market cap
$29.75M
P/E ratio
—
P/S ratio
1,352.38x
EPS (TTM)
$-2.73
Dividend yield
—
52W range
$1 – $4
Volume
0.2M
Senti Biosciences Inc (SNTI) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-37,095.00%
ROE
-218.10%
ROA
-48.90%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $85000.00 | $-21.16M | -16,987.06% | -25,625.88% | -24,890.59% |
| 2020 | $394000.00 | $-19.86M | 100.00% | -6,267.51% | -5,041.12% |
| 2021 | $2.29M | $-55.32M | 100.00% | -1,765.43% | -2,414.62% |
| 2022 | $4.29M | $-45.79M | 100.00% | -1,647.90% | -1,068.39% |
| 2023 | $1.98M | $-71.06M | 100.00% | -4,687.92% | -3,592.42% |
| 2024 | $0.00 | $-52.79M | — | — | — |
| 2025 | $22000.00 | $-61.44M | -16,431.82% | -289,668.18% | -279,263.64% |